Page last updated: 2024-08-21

2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and 1-methyl-4-phenylpyridinium

2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- has been researched along with 1-methyl-4-phenylpyridinium in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sonsalla, PK; Staal, RG1

Other Studies

1 other study(ies) available for 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and 1-methyl-4-phenylpyridinium

ArticleYear
Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Brain Chemistry; Dose-Response Relationship, Drug; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Microdialysis; Neostriatum; Neuropeptides; Neurotoxins; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Species Specificity; Synaptic Vesicles; Time Factors; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2000